Immunization, Hib3 in World
World: Immunization, Hib3 was 77.4% in 2024. ◆ Volatile
Immunization, Hib3 in World, 1990–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
In 2024, immunization, hib3 in World stood at 77.4%. That is the highest value across all 35 years on record.
The figure is up 1.0% on the previous year and up 41.8% over ten years.
Over the whole period, immunization, hib3 in World peaked at 77.4% in 2024 and was at its lowest, 0.0%, in 1990.
That places World 25th out of 43 groups with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, Hib3 in World, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1990 | 0.0% | — |
| 1991 | 0.5% | — |
| 1992 | 0.6% | +31.8% |
| 1993 | 1.3% | +100.6% |
| 1994 | 1.4% | +7.9% |
| 1995 | 4.2% | +203.4% |
| 1996 | 4.7% | +11.5% |
| 1997 | 5.2% | +10.4% |
| 1998 | 7.0% | +33.5% |
| 1999 | 7.9% | +12.8% |
| 2000 | 13.4% | +69.8% |
| 2001 | 14.0% | +4.8% |
| 2002 | 16.7% | +19.3% |
| 2003 | 17.5% | +4.9% |
| 2004 | 18.9% | +8.2% |
| 2005 | 20.1% | +6.1% |
| 2006 | 21.1% | +4.8% |
| 2007 | 24.5% | +16.5% |
| 2008 | 27.4% | +11.9% |
| 2009 | 38.2% | +39.0% |
| 2010 | 39.8% | +4.4% |
| 2011 | 42.5% | +6.8% |
| 2012 | 45.4% | +6.7% |
| 2013 | 50.1% | +10.5% |
| 2014 | 54.6% | +9.0% |
| 2015 | 62.4% | +14.3% |
| 2016 | 69.8% | +11.8% |
| 2017 | 71.1% | +1.9% |
| 2018 | 71.4% | +0.3% |
| 2019 | 73.0% | +2.2% |
| 2020 | 70.9% | -2.8% |
| 2021 | 71.1% | +0.2% |
| 2022 | 76.1% | +7.1% |
| 2023 | 76.6% | +0.7% |
| 2024 | 77.4% | +1.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 3.3% | 0.0% | 7.9% | 10 |
| 2000s | 21.2% | 13.4% | 38.2% | 10 |
| 2010s | 58.0% | 39.8% | 73.0% | 10 |
| 2020s | 74.4% | 70.9% | 77.4% | 5 |
More health data for World
- Population ages 15-19, male, annual growth rate 1.29 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0413 units per person (2025)
- Population ages 20-24, female, annual growth rate 0.7679 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0368 units per person (2025)
- Population ages 20-24, male, annual growth rate 0.8236 % change on previous year (2025)
- Population ages 20-24, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, male, per capita 0.0391 units per person (2025)
- Population ages 25-29, female, annual growth rate 0.3683 % change on previous year (2025)
Frequently asked questions
- What is immunization, hib3 in World?
- Immunization, hib3 in World was 77.4% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in World?
- The highest recorded value was 77.4% in 2024.
- What is the lowest immunization, hib3 recorded in World?
- The lowest recorded value was 0.0% in 1990.
- How does World rank for immunization, hib3?
- World ranks 25th out of 43 groups with data for 2024.
- Is immunization, hib3 rising or falling in World?
- Over the last ten years it is up 41.8%. The long-run trend across the full record is volatile.
- Where does this World data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.